Supports transformative, mechanistic research using nanotechnology to overcome major barriers in cancer biology/oncology, emphasizing fundamental understanding of nano–bio interactions, in vivo delivery to cancer targets, and characterization of diagnostic/detection devices in vitro. Clinical translation and clinical trials are out of scope.
Eligibility criteria:
-
Eligible U.S. applicant types include: public/private higher education institutions, nonprofits (with/without 501(c)(3)), for-profits (incl. small businesses), state/local/tribal governments, independent school districts, special districts, public housing authorities, and faith-/community-based and regional organizations.
-
Foreign (non-U.S.) organizations are not eligible; non-domestic components of U.S. organizations are not eligible.
-
Foreign components (per NIH policy) are allowed.
-
Activity code: R01; clinical trials not allowed.
Funding details:
-
Award ceiling: USD 475,000.
Deadlines:
-
Current closing date for applications: May 04, 2026.
Where to go for further information:
-
General inquiries: NIH Grants Information — [email protected].